Back to results
US 12,752,006 B2Granted
BCMA chimeric antigen receptors
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsShannon Grande Contrastano, Emily G. Kuiper
Life of this patent
Estimating the term…
Abstract
The disclosure provides improved compositions for adoptive T cell therapies for B cell related conditions.
Claims24
A chimeric antigen receptor (CAR) comprising:
- a) an extracellular domain comprising an anti-BCMA (B cell maturation antigen) antibody or antigen binding fragment thereof that binds one or more epitopes of a human BCMA polypeptide comprising variable light chain CDRL1, CDRL2, and CDRL3 regions within a variable light chain amino acid sequence and variable heavy chain CDRH1, CDRH2, and CDRH3 regions within a variable heavy chain amino acid sequence as set forth in any one of:
- SEQ ID NOs:
- 7 and 8, respectively;
- SEQ ID NOs:
- 15 and 16, respectively;
- SEQ ID NOs:
- 23 and 24, respectively;
- SEQ ID NOs:
- 31 and 32, respectively;
- SEQ ID NOs:
- 39 and 40, respectively;
- and
- SEQ ID NOs:
- 47 and 48, respectively;
- b) a transmembrane domain;
- c) one or more intracellular signaling domains.
13 more elements
Dependencies are inferred from the claim text.